The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Influence of adherence to adjuvant endocrine therapy in early breast cancer: Results from a large German real-world claims data analysis.
 
Dominik Dannehl
Travel, Accommodations, Expenses - Daiichi Sankyo Pharmaceutical
 
Tobias Engler
Honoraria - AstraZeneca; Daiichi Sankyo Pharmaceutical; Gilead Sciences; GlaxoSmithKline; Lilly O.; MSD; Novartis; Pfizer; Roche; Stemline Therapeutics
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Pharmaceutical; Gilead Sciences; GlaxoSmithKline; Lilly O.; MSD; Novartis; Pfizer; Roche; Stemline Therapeutics
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Pharmaceutical; Gilead Sciences; GlaxoSmithKline; Lilly O.; MSD; Novartis; Pfizer; Roche; Stemline Therapeutics
 
Tjeerd Dijkstra
No Relationships to Disclose
 
Raphael Gutsfeld
No Relationships to Disclose
 
Alexandra von Au
No Relationships to Disclose
 
Markus Hahn
No Relationships to Disclose
 
Sabine Hawighorst-Knapstein
No Relationships to Disclose
 
Ariane Chaudhuri
No Relationships to Disclose
 
Markus Wallwiener
Honoraria - Amgen; Celgene; Merck; MSD; Novartis; Roche; Storz
Consulting or Advisory Role - Amgen; MSD; Novartis; Pfizer; Roche
Research Funding - Amgen; MSD; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Amgen; MSD; Novartis; Pfizer; Roche
 
Armin Bauer
No Relationships to Disclose
 
Sara Brucker
Honoraria - Medtronic; MSD
Consulting or Advisory Role - AstraZeneca; Hologic; Lilly; Sanofi Aventis GmbH; Storz
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Eisai (Inst); Ethicon (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Hologic; Lilly; MSD; Storz
 
Stephanie Wallwiener
No Relationships to Disclose
 
Andreas Daniel Hartkopf
Honoraria - Agendia; Amgen; AstraZeneca; Clovis Oncology; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Hexal; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Consulting or Advisory Role - Agendia; Amgen; AstraZeneca; Clovis Oncology; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Hexal; Lilly; MSD; Novartis; Onkowissen; Pfizer; Pierre Fabre; Roche; Seagen
Speakers' Bureau - Agendia; Amgen; AstraZeneca; Clovis Oncology; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Hexal; Lilly; MSD; Novartis; Onkowissen; Pfizer; Pierre Fabre; Roche; Seagen
Research Funding - Exact Sciences (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Pfizer; Roche